Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Vollstedt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|January 13, 2009
Phenotype and function of neonatal DCFabienne Willems, Sabine Vollstedt, Mark Suter
European Journal of Immunology|April 28, 2006
The long-term but not the short-term antiviral effect of IFN-alpha depends on Flt3 ligand and pDCSabine Vollstedt, Meredith O'Keeffe, Beat Ryf, et al.
European Journal of Immunology|June 24, 2004
Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-alpha productionSabine Vollstedt, Meredith O'Keeffe, Bernhard Odermatt, et al.
Tuberculosis (Edinburgh, Scotland)|November 26, 2008
No evidence for association between the interferon regulatory factor 1 (IRF1) gene and clinical tuberculosisSabine Vollstedt, Rika Yuliwulandari, Koji Okamoto, et al.
Journal of Virology|March 30, 2004
Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1Sabine Vollstedt, Susi Arnold, Cornelia Schwerdel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old miceMarco Franchini, Hanspeter Hefti, Sabine Vollstedt, et al.
Nature Immunology|December 7, 2007
The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cellsShin-ichi Kano, Kojiro Sato, Yasuyuki Morishita, et al.
The Journal of Experimental Medicine|March 5, 2003
Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infectionsSabine Vollstedt, Marco Franchini, Hans P Hefti, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|January 13, 2009
Phenotype and function of neonatal DCFabienne Willems, Sabine Vollstedt, Mark Suter
European Journal of Immunology|April 28, 2006
The long-term but not the short-term antiviral effect of IFN-alpha depends on Flt3 ligand and pDCSabine Vollstedt, Meredith O'Keeffe, Beat Ryf, et al.
European Journal of Immunology|June 24, 2004
Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-alpha productionSabine Vollstedt, Meredith O'Keeffe, Bernhard Odermatt, et al.
Tuberculosis (Edinburgh, Scotland)|November 26, 2008
No evidence for association between the interferon regulatory factor 1 (IRF1) gene and clinical tuberculosisSabine Vollstedt, Rika Yuliwulandari, Koji Okamoto, et al.
Journal of Virology|March 30, 2004
Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1Sabine Vollstedt, Susi Arnold, Cornelia Schwerdel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old miceMarco Franchini, Hanspeter Hefti, Sabine Vollstedt, et al.
Nature Immunology|December 7, 2007
The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cellsShin-ichi Kano, Kojiro Sato, Yasuyuki Morishita, et al.
The Journal of Experimental Medicine|March 5, 2003
Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infectionsSabine Vollstedt, Marco Franchini, Hans P Hefti, et al.
Pageof 1